Surety Medicine 
Person demonstrating sleep - part of the Army's current "Performance Triade" emphasis - US Army photo 

AD-HOC JULY 30, 2014 SURETY MEDICINE TELECONFERENCE

Follow - Up Presentation: 
CASE STUDIES IN SLEEP DISORDERED BREATHING

An ad-hoc Surety Medicine Teleconference will offer an opportunity for one additional hour of Category 1 Continuing Medical Education in July.  On 30 July at 1300 hrs (1 p.m.) Eastern Time, a pulmonologist with extensive experience in treatment of Sleep Disordered Breathing and Obstructive Sleep Apnea will present case studies that may assist medical personnel with responsibility for Personnel Reliability Program patients in assessing the possible effects of sleep disorders on PRP worker performance.  This is a follow-up to the June 2014 teleconference on the same topic.

To receive access information for attending the presentation by dial-in audio or at your desk via Defense Connect Online, send an email request to:
usarmy.apg.medcom-phc.mbx.surety-medicine@mail.mil

 

Biohazard symbol with syringe and needle - CDC photo 

AUGUST 2014 SURETY MEDICINE TELECONFERENCE

HIV, CD4 COUNTS, ANTI-RETROVIRAL DRUGS,
AND IMPAIRED IMMUNE FUNCTION

How does HIV - positive status affect a worker's participation in the Personnel Reliability Program?  During the August 2014 Surety Medicine Teleconference, a division chief from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) discusses a process for immune function assessment and related biological exposure concerns for biological safety level laboratory workers. 

To receive access information for attending the presentation by dial-in audio or at your desk via Defense Connect Online, send an email request to:
usarmy.apg.medcom-phc.mbx.surety-medicine@mail.mil

____________________________________________________________________________________________________

 Join us for future Surety Medicine teleconferences:

SURETY MEDICINE TELECONFERENCE SCHEDULE FOR FY14
All conferences begin at 1300 hr / 1 p.m. Eastern Time (US)

Presentation Title

Date

(Topics and dates subject to change) 

 

HIV: CD4 Counts, Antiretroviral Drugs, and Impaired Immune Function 

20 August
    2014

 

Case Studies in Screening for Depression, Anxiety or Other Mood Disorders in PRP Candidates or Enrollees

 

      24 September 
     2014

NERVE AGENT ANTIDOTE KIT ALERT:  13 MAY 2014 UPDATE:

FDA further extends expiration dates of DuoDote(R)  auto-injector lots

The U.S. Food and Drug Administration has updated the 28 March, 2014 alert that certain lots of DuoDote®  (registered trademark, Meridian Medical Technologies) nerve agent/organophosphate auto-injectors may be used for up to two years beyond their labeled expiration dates.  Specific guidance, including applicable lot numbers, can be found at the FDA web page at:  http://www.fda.gov/Drugs/DrugSafety/ucm376367.htm